Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial
| Image |  |
|---|---|
| Description | scientific article published on 09 August 2019 |
| Author/s |
author: Kamyar Kalantar-Zadeh Peter Paul Toth |
| Publication date | August 9, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |